Sarah L. Belsey

Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling

Hugues de Lavallade, Ahmad Khoder, Melanie Hart et al. · Blood · 2013 · 108 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

A novel approach to quantitative LC-MS/MS: therapeutic drug monitoring of clozapine and norclozapine using isotopic internal calibration

Lewis Couchman, Sarah L. Belsey, Simon A. Handley et al. · Analytical and Bioanalytical Chemistry · 2013 · 24 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +16

Therapeutic monitoring of plasma clozapine and<i>N</i>-desmethylclozapine (norclozapine): practical considerations

Robert J. Flanagan, Siobhan Gee, Sarah L. Belsey et al. · BJPsych Advances · 2023 · 23 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men

Sarah L. Belsey, Robin Ireland, Kathryn Lang et al. · Therapeutic Drug Monitoring · 2017 · 16 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Buprenorphine Detection in Urine Using Liquid Chromatography–High-Resolution Mass Spectrometry: Comparison with Cloned Enzyme Donor Immunoassay (ThermoFisher) and Homogeneous Enzyme Immunoassay (Immunalysis)

Sarah L. Belsey, Lewis Couchman, Robert J. Flanagan · Journal of Analytical Toxicology · 2014 · 12 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +16